Identification of the endosomal sorting complex required for transport-I (ESCRT-I) as an important modulator of anti-miR uptake by cancer cells

Nucleic Acids Research

Volumn 43, Issue 2, 2015, Pages 1204-1215

  Wagenaar, Timothy R ^a   Tolstykh, Tatiana ^a   Shi, Chaomei ^a   Jiang, Lan ^a   Zhang, Jingxin ^a   Li, Zhifang ^a   Yu, Qunyan ^a   Qu, Hui ^a   Sun, Fangxian ^a   Cao, Hui ^a   Pollard, Jack ^a   Dai, Shujia ^a   Gao, Qiang ^a   Zhang, Bailin ^a   Arlt, Heike ^a   Cindhuchao, May ^a   Hoffmann, Dietmar ^a   Light, Madelyn ^a   Jensen, Karin ^a   Hopke, Joern ^a   Newcombe, Richard ^a   Garcia Echeverria, Carlos ^a   Winter, Christopher ^a   Zabludoff, Sonya ^b   Wiederschain, Dmitri ^a   more..

^a Sanofi Oncology   (United States)

^b REGULUS THERAPEUTICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; ESCRT PROTEIN; MICRORNA; MIRN21 MICRORNA, HUMAN; OLIGONUCLEOTIDE; TRANSCRIPTION FACTOR; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN;

ANIMAL; ANTAGONISTS AND INHIBITORS; FEMALE; GENETICS; HUMAN; METABOLISM; NEOPLASM; PHYSIOLOGY; SCID MOUSE; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; DNA-BINDING PROTEINS; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; FEMALE; HUMANS; MICE, SCID; MICRORNAS; NEOPLASMS; OLIGONUCLEOTIDES; TRANSCRIPTION FACTORS;

EID: 84941095121     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku1367     Document Type: Article

References (36)

1. Ameres,S.L. and Zamore,P.D. (2013) Diversifying microRNA sequence and function. Nat. Rev. Mol. Cell Biol., 14, 475-488.
2. Li,Y. and Kowdley,K.V. (2012) MicroRNAs in common human diseases. Genom. Proteom. Bioinformat., 10, 246-253.
3. Kozomara,A. and Griffiths-Jones,S. (2014) miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res., 42, D68-D73.
4. Volinia,S., Calin,G.A., Liu,C.G., Ambs,S., Cimmino,A., Petrocca,F., Visone,R., Iorio,M., Roldo,C., Ferracin,M. et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U.S.A., 103, 2257-2261.
5. Zhou,X., Wang,X., Huang,Z., Wang,J., Zhu,W., Shu,Y. and Liu,P. (2014) Prognostic value of miR-21 in various cancers: an updating meta-analysis. PloS ONE, 9, e102413.
6. Liu,G., Friggeri,A., Yang,Y., Milosevic,J., Ding,Q., Thannickal,V.J., Kaminski,N. and Abraham,E. (2010) miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J. Exp. Med., 207, 1589-1597.
7. Chau,B.N., Xin,C., Hartner,J., Ren,S., Castano,A.P., Linn,G., Li,J., Tran,P.T., Kaimal,V., Huang,X. et al. (2012) MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. Sci. Trans. Med., 4, 121ra118.
8. Thum,T., Gross,C., Fiedler,J., Fischer,T., Kissler,S., Bussen,M., Galuppo,P., Just,S., Rottbauer,W., Frantz,S. et al. (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature, 456, 980-984.
9. Leone,E., Morelli,E., Martino,M.T., Amodio,N., Foresta,U., Gulla,A., Rossi,M., Neri,A., Giordano,A., Munshi,N.C. et al. (2013) Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth. Clin. Cancer Res., 19, 2096-2106.
10. Thum,T., Chau,N., Bhat,B., Gupta,S.K., Linsley,P.S., Bauersachs,J. and Engelhardt,S. (2011) Comparison of different miR-21 inhibitor chemistries in a cardiac disease model. J. Clin. Invest., 121, 461-462; author reply 462-463.
11. Stenvang,J., Petri,A., Lindow,M., Obad,S. and Kauppinen,S. (2012) Inhibition of microRNA function by antimiR oligonucleotides. Silence, 3, 1.
12. Lennox,K.A. and Behlke,M.A. (2011) Chemical modification and design of anti-miRNA oligonucleotides. Gene Ther., 18, 1111-1120.
13. Kurreck,J. (2003) Antisense technologies. Improvement through novel chemical modifications. Eur. J. Biochem., 072, 4461-8261.
14. Li,Z. and Rana,T.M. (2014) Therapeutic targeting of microRNAs: current status and future challenges. Nat. Rev. Drug Discov., 13, 622-638.
15. Geary,R.S. (2009) Antisense oligonucleotide pharmacokinetics and metabolism. Expert Opin. Drug Metabol. Toxicol., 5, 381-391.
16. Khalil,I.A., Kogure,K., Akita,H. and Harashima,H. (2006) Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol. Rev., 58, 32-45.
17. Loke,S.L., Stein,C.A., Zhang,X.H., Mori,K., Nakanishi,M., Subasinghe,C., Cohen,J.S. and Neckers,L.M. (1989) Characterization of oligonucleotide transport into living cells. Proc. Natl. Acad. Sci. U.S.A., 86, 3474-3478.
18. Iversen,P.L., Zhu,S., Meyer,A. and Zon,G. (1992) Cellular uptake and subcellular distribution of phosphorothioate oligonucleotides into cultured cells. Antisense Res. Dev., 2, 211-222.
19. Alam,M.R., Ming,X., Dixit,V., Fisher,M., Chen,X. and Juliano,R.L. (2010) The biological effect of an antisense oligonucleotide depends on its route of endocytosis and trafficking. Oligonucleotides, 20, 103-109.
20. Koller,E., Vincent,T.M., Chappell,A., De,S., Manoharan,M. and Bennett,C.F. (2011) Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes. Nucleic Aacids Res., 39, 4795-4807.
21. Geary,R.S., Wancewicz,E.,Matson,J., Pearce,M., Siwkowski,A., Swayze,E. and Bennett,F. (2009) Effect of dose and plasma concentration on liver uptake and pharmacologic activity of a 2-methoxyethyl modified chimeric antisense oligonucleotide targeting PTEN. Biochem. Pharmacol., 78, 284-291.
22. Prakash,T.P., Graham,M.J., Yu,J., Carty,R., Low,A., Chappell,A., Schmidt,K., Zhao,C., Aghajan,M., Murray,H.F. et al. (2014) Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice. Nucleic Acids Res., 42, 8796-8807.
23. Babar,I.A., Cheng,C.J., Booth,C.J., Liang,X., Weidhaas,J.B., Saltzman,W.M. and Slack,F.J. (2012) Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc. Natl. Acad. Sci. U.S.A., 109, E1695-E1704.
24. Varkouhi,A.K., Scholte,M., Storm,G. and Haisma,H.J. (2011) Endosomal escape pathways for delivery of biologicals. J. Control. Release, 151, 220-228.
25. Whitehead,K.A., Langer,R. and Anderson,D.G. (2009) Knocking down barriers: advances in siRNA delivery. Nat. Rev. Drug Discov., 8, 129-138.
26. Stein,C.A., Hansen,J.B., Lai,J., Wu,S., Voskresenskiy,A., Hog,A., Worm,J., Hedtjarn,M., Souleimanian,N., Miller,P. et al. (2010) Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents. Nucleic Acids Res., 38, e3.
27. Liang,X.H., Shen,W., Sun,H., Prakash,T.P. and Crooke,S.T. (2014) TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells. Nucleic Acids Res., 42, 7819-7832.
28. Gottwein,E.,Mukherjee,N., Sachse,C., Frenzel,C., Majoros,W.H., Chi,J.T., Braich,R., Manoharan,M., Soutschek,J., Ohler,U. et al. (2007) A viral microRNA functions as an orthologue of cellular miR-155. Nature, 450, 1096-1099.
29. Yan,L.X., Wu,Q.N., Zhang,Y., Li,Y.Y., Liao,D.Z., Hou,J.H., Fu,J., Zeng,M.S., Yun,J.P., Wu,Q.L. et al. (2011) Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth. Breast Cancer Res., 13, R2.
30. Chen,L., Zhou,J.P., Kuang,D.B., Tang,J., Li,Y.J. and Chen,X.P. (2013) 4-HNE increases intracellular ADMA levels in cultured HUVECs: evidence for miR-21-dependent mechanisms. PloS ONE, 8, e64148.
31. Buscaglia,L.E. and Li,Y. (2011) Apoptosis and the target genes of microRNA-21. Chin. J. Cancer, 30, 371-380.
32. Katzmann,D.J., Babst,M. and Emr,S.D. (2001) Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell, 106, 145-155.
33. Schmidt,O. and Teis,D. (2012) The ESCRT machinery. Curr. Biol., 22, R116-R120.
34. Kostelansky,M.S., Sun,J., Lee,S., Kim,J., Ghirlando,R., Hierro,A., Emr,S.D. and Hurley,J.H. (2006) Structural and functional organization of the ESCRT-I trafficking complex. Cell, 125, 113-126.
35. Doyotte,A., Russell,M.R., Hopkins,C.R. and Woodman,P.G. (2005) Depletion of TSG101 forms a mammalian 'Class E' compartment: a multicisternal early endosome with multiple sorting defects. J. Cell Sci., 118, 3003-3017.
36. Sahay,G., Querbes,W., Alabi,C., Eltoukhy,A., Sarkar,S., Zurenko,C., Karagiannis,E., Love,K., Chen,D., Zoncu,R. et al. (2013) Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling. Nat. Biotechnol., 31, 653-658.